Kristina Sandgren
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological reference.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 23, 2025
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging.
Journal: Physics and imaging in radiation oncology
Published: June 28, 2024
Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 13, 2024
Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [ 68 Ga]PSMA-11-PET and [ 11 C]Acetate-PET.
Journal: Nuclear medicine communications
Published: August 24, 2023
The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography.
Journal: Communications medicine
Published: February 04, 2023
Registration of histopathology to magnetic resonance imaging of prostate cancer.
Journal: Physics and imaging in radiation oncology
Published: December 04, 2020
Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients.
Journal: EJNMMI physics
Published: June 28, 2018
Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy-A Systematic Review.
Journal: European urology focus
Published: June 12, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026